Results 191 to 200 of about 78,380 (259)

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1195-1207, July 2026.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat, Shawn G. Kwatra, Adam Reich, Serge Boulinguez, Athanasios Tsianakas, Maxwell Sauder, Sebastien Barbarot, Jacek C. Szepietowski, Curdin Conrad, Andrew E. Pink, Elke Weisshaar, Laurent Misery, Martin Metz, Vivian T. Laquer, Raja K. Sivamani, Gil Yosipovitch, Diamant Thaçi, Lone Skov, Xiaoxiao Chen, Aliene Noda, Zarif K. Jabbar‐Lopez, Christophe Piketty, Sonja Ständer   +22 more
wiley   +1 more source

Long-term all-cause mortality rate after ST-elevation myocardial infarction and its predictors: ST Elevation Myocardial Infarction Cohort in Isfahan Study. [PDF]

J Res Med Sci
Shojaei Y, Sadeghi M, Mehrabani K, Sadri M, Rouhani S, Hassannejad R, Roohafza H.   +6 more
europepmc   +1 more source

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL‐23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease

Journal of Gastroenterology and Hepatology, Volume 41, Issue 7, Page 2006-2029, July 2026.
ABSTRACT Ulcerative colitis (UC) and Crohn's disease (CD) are increasingly prevalent in the Asia Pacific region, necessitating updated, region‐specific guidance on advanced therapies. Targeted small molecule agents, such as filgotinib, tofacitinib, upadacitinib, etrasimod, and ozanimod; and the IL‐23 p19 inhibitors (guselkumab, mirikizumab ...
Choon Jin Ooi, Khoon Lin Ling, Julajak Limsrivilai, Shu‐Chen Wei, Joyce Wing Yan Mak, Taku Kobayashi, Luan Minh Dang, Rupert W. Leong, Huiyu Lin, Meng‐Tzu Weng, Wan Chee Ong, Vineet Ahuja, Satimai Aniwan, Ryota Hokari, Wei Jie Jonathan Lee, Alex Hwong‐Ruey Leow, Wai‐Keung Leung, Wee‐Chian Lim, Govind Makharia, Katsuyoshi Matsuoka, Nazri Mustaffa, Siew‐Chien Ng, Mathew Philip, Pises Pisespongsa, Raja Affendi Raja Ali, Zhi Hua Ran, Marcellus Simadibrata, Jose Sollano, Malcolm Tan, Hang Dao Viet, Nik Razima Wan Ibrahim, Kai Chun Wu, Byong Duk Ye, Ida Hilmi, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN‐IBD)   +34 more
wiley   +1 more source

Predictors of Adverse 30-Day Outcomes After Right Coronary Artery ST-Elevation Myocardial Infarction. [PDF]

J Clin Med
Bate AP, Franke KB, Nguyen E, Sutton D, Roberts-Thomson RL, Nelson AJ, Marathe JA, Psaltis PJ.   +7 more
europepmc   +1 more source

Haemodynamic‐energetic mechanism of sudden cardiac death in severe aortic stenosis: A modelling study

The Journal of Physiology, Volume 604, Issue 13, Page 5458-5492, 1 July 2026.
Abstract figure legend A sudden decrease in total peripheral resistance (TPR), as observed during vasovagal syncope, leads to a reduction in aortic systolic pressure (AO pressure) and afterload. In healthy individuals, the consequent decrease in left ventricular systolic pressure (LV pressure) lowers stroke work and myocardial energy expenditure.
Martin Dvoulety, Michal Sitina
wiley   +1 more source

Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. [PDF]

Cardiovasc Res
Leader JH, Vilahur G, Ajjan RA, Kanji R, Gue YX, Farag M, Gorog DA.   +6 more
europepmc   +1 more source

Assessment of the Effectiveness of Early Versus Delayed Invasive Strategies in Non-ST Elevation Myocardial Infarction (NSTEMI): A Systematic Review and Meta-Analysis. [PDF]

Cureus
Kamble A, Revunuru NR, Rangachari B, Bharat Patel V, Ullah I, Ahmed Z.   +5 more
europepmc   +1 more source

Frailty first: Rethinking invasive strategies for elderly patients with non-ST-elevation myocardial infarction. [PDF]

World J Cardiol
Milaras N, Toutouzas K, Sideris S.
europepmc   +1 more source

Transfer and Survival of ST-Elevation Myocardial Infarction Medicare Patients. [PDF]

Cardiol Res
Leeberg M, Shermeyer A, Ward MJ, Virnig B, Wolfson J, Carroll C, Nikpay S.   +6 more
europepmc   +1 more source